Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;6(4):299-305.
doi: 10.4306/pi.2009.6.4.299. Epub 2009 Nov 11.

Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia

Jung Goo Lee  1 , Bae Sub Shin, Young Sun You, Ji Eun Kim, Sung Wook Yoon, Dong Wook Jeon, Jun Hyung Baek, Sung Woo Park, Young Hoon Kim
Affiliations

Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia

Jung Goo Lee et al. Psychiatry Investig. 2009 Dec.

Abstract

Objective: The primary purpose of this study was to investigate the differences in the serum brain-derived neurotrophic factor (BDNF) level between elderly Korean people over 65 years with and without dementia.

Methods: 171 individuals over 65 years were enrolled in this study. Screening for cognitive impairments was carried out using the Mini-Mental Status Examination-Korean version (MMSE-KC). One hundred thirty-two subjects scored below 1.5 standard deviations (SD) of the mean MMSE-KC score, and these were evaluated using the Consortium to Establish a Registry for Alzheimer's Disease, Korean version (CERAD-K) and the Geriatric Depression Scale (GDS). The Clinical Dementia Rating Scale (CDRS) and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnostic criteria were used for further evaluation. Subjects with a CDRS score of 1 or higher were classified as having Alzheimer's disease (AD), and subjects with a CDRS score of 0.5 were classified as having a mild cognitive impairment (MCI). Subjects with a CDRS score of 0 were classified as having aging-associated cognitive decline (AACD). Serum BDNF levels were analyzed using the enzyme-linked immunosorbent assay (ELISA) method.

Results: The serum BDNF levels were significantly lower in the subjects with MCI and AD compared with the healthy controls (p<0.01). A significant correlation was found between the total MMSE-KC score and serum BDNF level (r=0.295; p<0.01). However, no significant correlation was observed between the severity of MMSE-KC and the total GDS score. A significant difference was found in the total score of GDS between the AACD group and subjects with AD (p<0.05).

Conclusion: This study suggested that BDNF might be involved in the pathophysiology of cognitive decline in elderly people.

Keywords: Alzheimer's disease; Brain-derived neurotrophic factor; Depression; Mild cognitive impairment.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Serum BDNF levels of subjects. **p<0.01. BDNF: brain-derived neurotrophic factor, AACD: age-associated cognitive decline, MCI: mild cognitive impairment, AD: Alzheimer's disease.
FIGURE 2
FIGURE 2
Mean GDS scores of subjects with MMSE-KC score 1.5 SD below. **p<0.01. GDS: geriatric depression scale, MMSE-KC: Mini Mental State Examination of Korean version, SD: standard deviation, AACD: age-associated cognitive decline, MCI: mild cognitive impairment, AD: Alzheimer's disease.
FIGURE 3
FIGURE 3
Serum BDNF levels in the two groups with (GDS≥20) or without severe depression (GDS<20). BDNF: brain-derived neurotrophic factor, GDS: geriatric depression scale.
FIGURE 4
FIGURE 4
Correlation between serum BDNF levels and total scores of MMSE-KC in all subjects. BDNF: brain-derived neurotrophic factor, MMSE-KC: Mini Mental State Examination of Korean version
See this image and copyright information in PMC

References

    1. Dugu M, Neugroschl J, Sewell M, Marin D. Review of dementia. Mt Sinai J Med. 2003;70:45–53. - PubMed
    1. Cotter VT. The burden of dementia. Am J Manag Care. 2007;13(Suppl 8):S193–S197. - PubMed
    1. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–260. - PubMed
    1. Blasko I, Grubeck-Loebenstein B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging. 2003;20:101–113. - PubMed
    1. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 Suppl 1):2620–2622. - PubMed

LinkOut - more resources